ONLY VIRTUE IS TAKEN, ONLY TALENT IS USED!

唯贤是取，唯才是用！

    Rebiosun (ZheJiang) Pharmaceutical Co., Ltd. is a high-tech innovative enterprise with independent intellectual property rights and technology, specializing in the research, development, production and sales of natural plant innovative drugs.

    The company takes tackling major human diseases as its own responsibility. Under the leadership of Dr. Li Ming, a returnee from overseas, the company applies modern medical research technology and combines the Integrate medical theory and practice, explore effective active ingredients of natural plants, develop innovative drugs, and achieve curative treatment of major diseases.

TAKING IT AS OUR RESPONSIBILITY TO CONQUER MAJOR HUMAN DISEASES

By applying modern medical research techniques and combining traditional medicine theory and practice, we aim to discover effective active ingredients from natural plants and develop innovative drugs

What is stroke?

Stroke, also known as cerebrovascular accident "stroke", is an acute vascular disease that damages brain tissue due to insufficient blood supply or rupture of cerebral blood vessels caused by cerebral vascular obstruction.

What is ischemic stroke?

Ischemic stroke (commonly known as cerebral infarction) refers to a clinical event in which the blood supply artery to the brain is narrowed or occluded, resulting in neurological dysfunction due to insufficient blood supply to the brain, including transient ischemic attack (TIA), reversible neurological dysfunction (RIND), progressive stroke (SIP), and complete stroke (CS).

Research and development of Class 1 new drugs for stroke treatment

Dr. Li Ming has been engaged in research on cardiovascular and cerebrovascular diseases, focusing on the development of stroke drugs. Through the methods of regenerative medicine, effective parts extracted from natural plants are used to induce and promote the regeneration of new blood vessels in the ischemic area of the brain, forming new collateral circulation, substantially increasing cerebral blood flow and blood supply to the ischemic area of the brain, fundamentally improving cerebral ischemia.

The advantages and social value of innovative stroke drugs

The Class 1 new drugs for ischemic stroke have the characteristics and advantages of innovation, effectiveness, safety, controllability, and wide application. They can be applied in the acute phase, recovery phase, sequelae phase, as well as primary and secondary prevention of ischemic stroke.